| TITRE |
Un registre exhaustif et observationnel des néoplasies myéloprolifératives dans la province du Québec (Registre des NMP) |
| PROTOCOLE ID |
Registre des NMP (CINC424BCA04T) |
| CLINICAL TRIAL.gov ID |
|
| TYPE(S) DE CANCER |
NMP : Vaquez , Thrombocythémie essentielle, Métaplasie myéloide |
| PHASE |
Autres |
| TYPE D'ÉTUDE |
|
| INSTITUTION |
CISSS DE LAVAL
1755 boul. René-Laennec
(450) 668-1010
|
| VILLE |
Laval
|
| INVESTIGATEUR(RICE) PRINCIPAL(E) |
Danielle Talbot
|
| COORDONATEUR(RICE) |
Solange Tremblay
stremblay.csssl@ssss.gouv.qc.ca
450-668-1010 poste 23603
|
| STATUT |
Actif en recrutement
|
| CRITÈRES D'ÉLIGIBILITÉ |
(EN) All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
- Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
- Are 18 years of age or older;
- Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable.
|
| CRITÈRES D'EXCLUSION |
(EN) Patients who meet any of the following criteria will be excluded from participation:
- Life expectancy of less than 3 months for a condition not related to MPN;
- Patients suffering of CML.
|
